CRBU Reports $11.2M Licensing Rev, $23.8M Q4 R&D, $21.3M Impairment Charge
Caribou Biosciences, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $2.43
+42% since the alert
$1.71 → $2.43
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS